Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyFlorida Blue specialty drug coverage & Prior Auth …
    Ask Trek AI about this page
    CurrentFlorida BluePolicy N/A

    Newly Marketed and Specialty Prescription Drug Coverage and Utilization Controls

    Customize your policy alerts

    Sign up for all Florida Blue policy alerts

    Know when Florida Blue releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governance of coverage, prior authorization, quantity limits, limited distribution designation, and preferred specialty pharmacy arrangements for newly marketed and specialty prescription medications for Florida Blue members; affects prescribers, pharmacies, and members covered by Florida Blue plans.

    Policy Summary
    PayerFlorida Blue
    PolicyNewly Marketed and Specialty Prescription Drug Coverage and Utilization Controls
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionRefer to member contract benefits and the Prior Authorization Program Information and Forms to determine whether prior authorization is required.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    multipledrugs enumerated
    LDD, PA, QL

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    common designations
    presentnot covered entries
    CVS/Caremarkpreferred pharmacy

    Coverage Criteria and Drug Listings

    Coverage criteria and utilization controls

    Coverage status and utilization management for listed specialty and newly marketed drugs.

    Pharmacy & Therapeutics Committee review required before newly marketed drugs are covered or tiered
    Prior Authorization (PA) may be required for many listed specialty drugs; refer to the member contract benefit and the Prior Authorization Program Information and Forms to determine PA requirements
    Certain specialty drugs may be designated as Limited Distribution Drugs (LDD) and must be dispensed from the specified dispensing pharmacy listed on the Limited Distribution Drugs resource
    Drugs may be covered as self‑administered or provider‑administered specialty pharmacy products; member cost share for self‑administered specialty drugs may be higher if not obtained from an in‑network specialty pharmacy (CVS/Caremark is the preferred in‑network pharmacy for hemophilia products)

    Coverage exceptions and exclusions

    • Some listed drugs are explicitly marked NOT COVERED; coverage varies by drug and by plan — claims for NOT COVERED drugs are subject to denial
    Quantity limits (QL) often apply to many listed specialty drugs; check the drug listing for QL designations

    Coverage Indicators and Not Covered Items

    Drugs are listed with indicators showing whether they are limited distribution, require prior authorization, have quantity limits, and whether they are covered or not covered under the pharmacy benefit.

    Examples of covered or subject-to-controls

    • tadalafil (for PAH) — PA, QL
    • Xolair — LDD, PA, QL
    • Yutrepia — LDD, PA, QL
    • Zarxio — PA

    Examples of drugs marked NOT COVERED

    • Gilenya — LDD, PA, QL, NOT COVERED

    Drug Designations and Plan Indicators

    Drug designation codesmixed
    LDDLimited Distribution Drug (Dispensing pharmacy can be found here: Limited Distribution Drugs)
    PAPrior Authorization
    QLQuantity Limit
    Plan list indicatorsmixed
    LDDLimited Distribution Drug
    PAPrior Authorization
    QLQuantity Limit

    Provider Responsibilities, Prior Authorization, and Pharmacy Access

    Prior Authorization

    Prior authorization and limited distribution guidance

    Prior Authorization requirements vary by plan; determine PA enrollment and coverage by consulting the member contract benefit and the Prior Authorization Program Information and Forms. Certain specialty drugs may be Limited Distribution Drugs and are only available from specific specialty pharmacies (see Limited Distribution Drugs for dispensing pharmacy locations).

    • Check member contract benefit for PA program inclusion.
    • Use Prior Authorization Program Information and Forms to determine coverage.
    • If drug is LDD, confirm designated dispensing pharmacy from the Limited Distribution Drugs resource.
    Billing Rule

    Cost share and preferred pharmacy

    Abbreviations and Definitions

    LDD — Limited Distribution Drug
    TermLDD (Limited Distribution Drug)
    DefinitionLimited Distribution Drug — dispensed only from designated dispensing pharmacies
    ReferenceDispensing pharmacy list available at: Limited Distribution Drugs (see source list)
    PA — Prior Authorization
    TermPA (Prior Authorization)
    DefinitionPrior Authorization — prior approval required to determine coverage
    NotePA requirements may vary by plan; refer to member contract and PA Program Information and Forms
    Policy Summary
    PayerFlorida Blue
    PolicyNewly Marketed and Specialty Prescription Drug Coverage and Utilization Controls
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionRefer to member contract benefits and the Prior Authorization Program Information and Forms to determine whether prior authorization is required.
    SourceLink
    On This Page
    Coverage Criteria and Drug ListingsDrug Designations and Plan IndicatorsProvider Responsibilities, Prior Authorization, and Pharmacy AccessAbbreviations and Definitions
    Gleevec — PA, QL, NOT COVERED
  1. Abrilada — PA, QL, NOT COVERED
  2. Xyrem — LDD, PA, QL, NOT COVERED
  3. Xeloda — NOT COVERED
  4. Legend: LDD = Limited Distribution Drug; PA = Prior Authorization; QL = Quantity Limit

    Member cost share may be higher when self-administered specialty drugs are not obtained from an in-network specialty pharmacy. CVS/Caremark is identified as the preferred in‑network specialty pharmacy for hemophilia products.

    • Advise members about potential higher cost share for out-of-network specialty pharmacy dispensing.
    • Use CVS/Caremark for hemophilia specialty products when appropriate to align with preferred in-network arrangements.
    Prior Authorization

    Prior Authorization and Quantity Limits Apply

    Many specialty drugs listed require Prior Authorization (PA) and are subject to Quantity Limits (QL); some listed products are designated Limited Distribution Drugs (LDD) and must be dispensed from specified pharmacies.

    • Verify PA and QL requirements for each drug prior to prescribing or dispensing (examples in drug lists show PA and QL flags).
    • If a drug is labeled LDD, arrange dispensing through the designated specialty pharmacy.
    Denial Risk

    Denial risk for NOT COVERED drugs

    Drugs marked NOT COVERED in the listings indicate a coverage exclusion or risk of claim denial if coverage criteria are not met; confirm plan-specific coverage before prescribing or dispensing.

    • Do not assume coverage for medications flagged NOT COVERED; obtain PA only when applicable and verify benefit inclusion.
    • Contact Customer Service (number on member ID card) for plan-specific coverage questions or to confirm alternatives.
    QL — Quantity Limit
    TermQL (Quantity Limit)
    DefinitionQuantity Limit — maximum allowed quantity under the benefit for a given time period
    NoteMany specialty drugs listed include QL designations; check product-specific limits
    LDD — Limited Distribution Drug
    TermLDD (Limited Distribution Drug)
    DefinitionLimited Distribution Drug — dispensed only from designated dispensing pharmacies (see Limited Distribution Drugs list)
    ExampleExamples on list: Winrevair, Xalkori, Xolair (marked LDD)
    PA — Prior Authorization
    TermPA (Prior Authorization)
    DefinitionPrior Authorization — approval required before drug is covered under the benefit
    ExampleExamples on list: tadalafil (for PAH), Xeljanz (marked PA)
    QL — Quantity Limit
    TermQL (Quantity Limit)
    DefinitionQuantity Limit — specified maximum quantity (per time period) applied to claims for the drug
    ExampleExamples on list: tadalafil (for PAH), Xalkori (marked QL)